文献速递临床试验与 GCP

去甲肾上腺素与去氧肾上腺素对脊髓麻醉剖宫产患者促血栓反应影响的随机双盲对照研究方案

Effect of norepinephrine and phenylephrine on prothrombotic response in patients undergoing cesarean section under spinal anesthesia: protocol for a randomized, double-blind, controlled study.
PubMed 文献 · Trials · 2024-07-02

本研究为随机双盲对照试验方案,拟纳入66例在脊髓麻醉下接受剖宫产的产妇,随机分为去甲肾上腺素组或去氧肾上腺素组,研究药物自鞘内注射起以15 ml/h速率给药,主要结局为血浆凝血因子VIII活性、纤维蛋白原和D-二聚体水平,次要结局包括血流动力学变量和脐动脉血pH值。

要点

  • 拟纳入66例脊髓麻醉剖宫产产妇,随机分为去甲肾上腺素组与去氧肾上腺素组。
  • 研究药物自鞘内注射起以15 ml/h速率给药。
  • 主要结局为血浆凝血因子VIII活性、纤维蛋白原和D-二聚体水平。

核心结论

  • 本研究为首次比较去甲肾上腺素与去氧肾上腺素对脊髓麻醉剖宫产患者促血栓反应影响的试验,阳性或阴性结果均有助于理解血管活性药物对患者的影响。

研究设计与样本

  • 随机、双盲、对照研究方案,拟招募66例符合条件的产妇,随机分配至去甲肾上腺素组或去氧肾上腺素组。
  • 研究药物自鞘内注射起以15 ml/h速率给药。

主要发现

  • 主要结局为血浆凝血因子VIII活性(FVIII:C)、纤维蛋白原和D-二聚体水平。
  • 次要结局包括血流动力学变量和脐动脉血pH值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Norepinephrine and phenylephrine are commonly used vasoactive drugs to treat hypotension during the perioperative period. The increased release of endogenous norepinephrine elicits prothrombotic changes, while parturients are generally in a hypercoagulable state. Therefore, this trial aims to investigate whether there is a disparity between equivalent doses of prophylactic norepinephrine infusion and phenylephrine infusion on prothrombotic response in patients undergoing cesarean section under spinal anesthesia. METHODS: Sixty-six eligible parturients will be recruited for this trial and randomly assigned to the norepinephrine or phenylephrine group. The "study drug" will be administered at a rate of 15 ml/h starting from the intrathecal injection. The primary outcome are plasma coagulation factor VIII activity (FVIII: C), fibrinogen, and D-dimer levels. The secondary outcomes include hemodynamic variables and umbilical artery blood pH value. DISCUSSION: Our study is the first trial comparing the effect of norepinephrine and phenylephrine on prothrombotic response in patients undergoing cesarean section under spinal anesthesia. Positive or negative results will all help us better understand the impact of vasoactive drugs on patients. If there are any differences, this trial will provide new evidence for maternal choice of vasoactive medications in the perioperative period. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2300077164. Registered on 1 November 2023. https://www.chictr.org.cn/ .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Tao W, Xie Y, Ding W, et al. Effect of norepinephrine and phenylephrine on prothrombotic response in patients undergoing cesarean section under spinal anesthesia: protocol for a randomized, double-blind, controlled study. Trials. 2024. PMID: 38956697. doi:10.1186/s13063-024-08255-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。